Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Infections

Explore clinical trials studying Respiratory Tract Infections. Study availability and eligibility vary by location and protocol.

9,627 public trials 646 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Infections trial results

Completed

Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID.

NCT05601180

Conditions
Asthma, Bronchial Diseases, COVID-19, +27 more
Locations
  • CHU Beni Messous/Pneumologie A Algiers, Algeria
  • CHU Beni Messous/Pneumologie B Algiers, Algeria
  • CHU Annaba/Pneumo-phtisiologie Annaba, Algeria
  • EPH Batna/Pneumo-phtisiologie Batna City, Algeria
View Trial Details
Completed

Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults

NCT04785144

Conditions
COVID-19, COVID-19 Immunisation, Coronaviridae Infections, +10 more
Locations
  • The Hope Clinic of Emory University Decatur, Georgia, United States
  • Cincinnati Children's Hospital Medical Center Vaccine Research Center Cincinnati, Ohio, United States
  • Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center Nashville, Tennessee, United States
  • Kaiser Permanente Washington Health Research Institute Seattle, Washington, United States
View Trial Details
Completed

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)

NCT04283461

Conditions
COVID-19, COVID-19 Immunisation, Coronaviridae Infections, +10 more
Locations
  • The Hope Clinic of Emory University Decatur, Georgia, United States
  • National Institutes of Health - Clinical Center - Vaccine Research Center Clinical Trials Program Bethesda, Maryland, United States
  • Kaiser Permanente Washington Health Research Institute Seattle, Washington, United States
View Trial Details
Completed

Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1

NCT01006798

Conditions
Animal Diseases, Bird Diseases, Bird Flu, +9 more
Locations
  • University of Kentucky Lexington, Kentucky, United States
  • The Center for Pharmaceutical Research Kansas City, Missouri, United States
  • University of Rochester Rochester, New York, United States
  • Coastal Carolina Research Center, Inc. Mt. Pleasant, South Carolina, United States
View Trial Details
Completed

Performance Evaluation of the Lucira COVID-19 & Flu Test

NCT06141824

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Cullman Clinical Trials Cullman, Alabama, United States
  • Benchmark Research Colton, California, United States
  • Carbon Health Oakland, California, United States
  • Koch Family Medicine Morton, Illinois, United States
View Trial Details

Related conditions